American Journal of Cardiology
Volume 105, Issue 1 , Pages 59-63 , 1 January 2010

Mechanical Complications After Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction (from APEX-AMI)

  • John K. French, MBChB, PhD

      Affiliations

    • Cardiology Department, University of New South Wales, Liverpool Hospital, Sydney, New South Wales, Australia
    • Corresponding Author InformationCorresponding author: Tel: 61-2-9828-3069; fax: 61-2-9828-3341
    • ,
  • Anne S. Hellkamp, MS

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina
    • ,
  • Paul W. Armstrong, MD

      Affiliations

    • University of Alberta, Edmonton, Alberta, Canada
    • ,
  • Eric Cohen, MD

      Affiliations

    • Sunnybrook and Women's College Health Sciences Centre, Sunnybrook, Ontario, Canada
    • ,
  • Neil S. Kleiman, MD

      Affiliations

    • Methodist Hospital, Houston, Texas
    • ,
  • Christopher M. O'Connor, MD

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina
    • ,
  • David R. Holmes, MD

      Affiliations

    • Mayo Clinic, Rochester, Minnesota
    • ,
  • Judith S. Hochman, MD

      Affiliations

    • New York University Medical Center, New York, New York
    • ,
  • Christopher B. Granger, MD

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina
    • ,
  • Kenneth W. Mahaffey, MD

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina

Received 5 March 2009 ,Revised 4 August 2009 ,Accepted 4 August 2009.

References 

  1. Goldberg RJ, Gore JM, Alpert JS, Osganian V, De Groot J, Bade J, et al. Cardiogenic shock after acute myocardial infarction: incidence and mortality from a community wide perspective 1975–1988. N Engl J Med. 1991;325:1117–1122
  2. Goldberg RJ, Samad NA, Yarzebski J, Gurwitz J, Bigelow C, Gore JM. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med. 1999;340:1162–1168
  3. Patel MR, Meine TJ, Lindblad L, Griffin J, Granger CB, Becker RC, et al. Cardiac tamponade in the fibrinolytic era: analysis of >100000 patients with ST-segment elevation myocardial infarction. Am Heart J. 2006;151:316–322
  4. Birnbaum Y, Fishbein MC, Blanche C. Ventricular septal rupture after acute myocardial infarction. N Engl J Med. 2002;347:1426–1432
  5. Moreno R, López-Sendón J, Garcia E, Pérez de Isla L, López de Sá E, Ortega A, et al. Primary angioplasty reduces the risk of left ventricular free wall rupture compared with thrombolysis in patients with acute myocardial infarction. J Am Coll Cardiol. 2002;39:598–603
  6. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med. 1999;341:625–634
  7. Armstrong PW, Granger CB, Adams PX, Hamm C, Holmes D, O'Neill WW, et al. Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial. JAMA. 2007;297:43–51
  8. French JK, Williams BF, Hart HH, Wyatt S, Poole JE, Ingram C, et al. Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction. BMJ. 1996;312:1637–1641
  9. Hochman JS, Buller CE, Sleeper LA, Boland J, Dzavik V, Sanborn TA, et al. Cardiogenic shock complicating acute myocardial infarction—etiologies, management and outcome: a report from the SHOCK Trial Registry. J Am Coll Cardiol. 2000;36:1063–1070
  10. Sanborn TA, Sleeper LA, Webb JG, French JK, Bergman G, Parikh M, et al. Correlates of one-year survival in patients with cardiogenic shock complicating acute myocardial infarction: angiographic findings from the SHOCK trial. J Am Coll Cardiol. 2003;42:1373–1379
  11. Wong SC, Sanborn T, Sleeper LA, Webb JG, Pilchik R, Hart D, et al. Angiographic findings and clinical correlates in patients with cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK trial registry (SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?). J Am Coll Cardiol. 2000;36:1077–1083
  12. Sugiura T, Nagahama Y, Nakamura S, Kudo Y, Yamasaki F, Iwasaka T. Left ventricular free wall rupture after reperfusion therapy for acute myocardial infarction. Am J Cardiol. 2003;92:282–284
  13. Crenshaw BS, Granger CB, Birnbaum Y, Pieper KS, Morris DC, Kleiman NS, et al. Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. Circulation. 2000;101:27–32
  14. Bueno H, Martínez-Sellés M, Pérez-David E, López-Palop R. Effect of thrombolytic therapy on the risk of cardiac rupture and mortality in older patients with first acute myocardial infarction. Eur Heart J. 2005;26:1705–1711
  15. Malek G, Massad MD, Alexander SG. Surgical repair of mechanical complications of myocardial infarction. World J Surg. 2004;28:847–856
  16. Holzer R, Balzer D, Amin Z, Ruiz CE, Feinstein J, Bass J, et al. Transcatheter closure of postinfarction ventricular septal defects using the new Amplatzer muscular VSR occluder: results of a US registry. Catheter Cardiovasc Interv. 2004;61:196–201

PII: S0002-9149(09)02218-8

doi: 10.1016/j.amjcard.2009.08.653

American Journal of Cardiology
Volume 105, Issue 1 , Pages 59-63 , 1 January 2010

Article Tools

* Image Usage & Resolution